ArticleImmunohistochemical Expression of SOX2 and EpCAM in Colorectal Cancer and its Precancerous lesions
ArticleImmunohistochemical Expression of SOX2 and EpCAM in Colorectal Cancer and its Precancerous lesions
ArticleAssessment of Immunohistochemical Expression of SOX2 and its Prognostic Significance in Prostatic Adenocarcinoma
ArticleAssessment of Immunohistochemical Expression of SOX2 and its Prognostic Significance in Prostatic Adenocarcinoma
ArticlePrognostic relevance of immunohistochemical expression of Sox2, YAP1, and IMP3 in non-muscle invasive bladder cancer
ArticlePrognostic relevance of immunohistochemical expression of Sox2, YAP1, and IMP3 in non-muscle invasive bladder cancer
ArticleClinicopathological Impact of CPA4, UHRF1, Glypican-1, and CD90 Expression in Lung Adenocarcinoma and Epithelioid Malignant Mesothelioma
ArticleClinicopathological Impact of CPA4, UHRF1, Glypican-1, and CD90 Expression in Lung Adenocarcinoma and Epithelioid Malignant Mesothelioma
ArticleImmunohistochemical Expression of Sex Determining Region Y-Box 2 inOral Squamous Cell Carcinoma
ArticleImmunohistochemical Expression of Sex Determining Region Y-Box 2 inOral Squamous Cell Carcinoma
ArticleAssociation of CTLA4 and PD-L1 immunohistchemical expression with various clinicopathological parameters and survival in non–small-cell lung cancer
ArticleAssociation of CTLA4 and PD-L1 immunohistchemical expression with various clinicopathological parameters and survival in non–small-cell lung cancer
ArticleThe Role of CD44 AND SOX-2 Cancer Stem cell Markers in The Development and Progression of Mucoepidermoid Carcinoma and Primary Squamous Cell Carcinoma of Salivary Glands
ArticleThe Role of CD44 AND SOX-2 Cancer Stem cell Markers in The Development and Progression of Mucoepidermoid Carcinoma and Primary Squamous Cell Carcinoma of Salivary Glands
ArticleHistopathological and Immunohistochemical Study of D2-40 Expression in Malignant Pleural Mesothelioma and Metastatic Adenocarcinoma
ArticleHistopathological and Immunohistochemical Study of D2-40 Expression in Malignant Pleural Mesothelioma and Metastatic Adenocarcinoma